SCHEMBL8063754

SCHEMBL8063754

O=C(/C=C/c1ccc([N+](=O)[O-])cc1)Nc1cccc(C(=O)O)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 8/20 0.77
MAPT P10636 7/20 0.77
MEN1 O00255 7/20 0.77
ALDH1A1 P00352 3/20 0.77
MAPK1 P28482 2/20 0.77
SMN1; SMN2 Q16637 4/20 0.71
LMNA P02545 2/20 0.71
LTB4R Q15722 1/20 0.70
RAB9A P51151 5/20 0.68
NPC1 O15118 4/20 0.68
TDP1 Q9NUW8 1/20 0.68
PKM P14618 1/20 0.65
PAX8 Q06710 1/20 0.65
CYP1A2 P05177 1/20 0.62
CYP3A4 P08684 1/20 0.62
CYP2C19 P33261 1/20 0.62
POLB P06746 2/20 0.62
TRPV1 Q8NER1 4/20 0.58
BCHE P06276 1/20 0.56
MAOB P27338 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8063757 1.00 KMT2A (0.77) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL8065947 0.89 MEN1 (0.84) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL8065945 0.89 MEN1 (0.84) KMT2AMAPTMEN1ALDH1A1MAPK1
4-Nitro-Cinnamanilide SCHEMBL3021597 0.86 MAPT (0.72) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL8049032 0.84 LTB4R (0.84) KMT2AMAPTMEN1SMN1; SMN2LMNA
SCHEMBL8049033 0.84 LTB4R (0.84) KMT2AMAPTMEN1SMN1; SMN2LMNA
SCHEMBL20526857 0.84 KMT2A (0.73) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL20526855 0.84 KMT2A (0.73) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL30967986 0.84 KMT2A (0.73) KMT2AMAPTMEN1ALDH1A1MAPK1
SCHEMBL23547197 0.82 TRPV1 (0.73) KMT2AMAPTMEN1ALDH1A1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6127392-A A MUSCLE RELAXANT FOR TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION; INOTROPIC AGENT AMERICAN HOME PRODUCTS CORPORATION (US) 2000-10-03 US disclosed
US-6046239-A USED IN THE TREATMENT OF DISORDERS ASSOCIATED WITH SMOOTH MUSCLE CONTRACTION, VIA POTASSIUM CHANNEL AND CHLORIDE CHANNEL MODULATION SUCH AS URINARY INCONTINENCE, ASTHMA, ANGINA, PREMATURE LABOR, CONGESTIVE HEART FAILURE AMERICAN HOME PRODUCTS CORPORATION (US) 2000-04-04 US disclosed